This is still ground-breaking research for MMJ and how the body accepts the different combinations as well as how fast it accepts these formulations. From this point our researchers may be able to identify the best potential candidates(cancer-wise or other health conditions) for research on the clinical front.

I do like this ability to provide two different delivery systems. The pharmacokenetics will show the rate of absorbtion and duration of a particular MMJ formulation PER delivery system. Just hoping our legal team is linked with the Souresky Hospital so we get that "patent applied for" credential.